DOCM 📈 DocMorris - Overview
Exchange: SW • Country: Switzerland • Currency: CHF • Type: Common Stock • ISIN: CH0042615283
DOCM: Medicines, Supplements, Beauty Products, Painkillers, First Aid Items
DocMorris AG operates e-commerce pharmacies and a wholesale business for medical and pharmaceutical products in Switzerland and internationally. The company offers prescription and over-the-counter medicines, consumer health products, beauty and personal care products, nutritional supplements, painkillers, and first aid products. It also provides professional health care services. The company sells its products to online mail-order pharmacies, and private individuals under the PromoFarma by DocMorris, TeleClinic, and DocMorris brands. The company was formerly known as Zur Rose Group AG and changed its name to DocMorris AG in May 2023. DocMorris AG was founded in 1993 and is headquartered in Frauenfeld, Switzerland. Web URL: https://corporate.docmorris.com/en
Additional Sources for DOCM Stock
DOCM Stock Overview
| Market Cap in USD | 351m |
| Sector | Healthcare |
| Industry | Pharmaceutical Retailers |
| GiC Sub-Industry | Drug Retail |
| IPO / Inception |
DOCM Stock Ratings
| Growth 5y | -89.0% |
| Fundamental | -59.7% |
| Dividend | - |
| Rel. Strength Industry | -618 |
| Analysts | - |
| Fair Price Momentum | 13.07 CHF |
| Fair Price DCF | - |
DOCM Dividends
No Dividends PaidDOCM Growth Ratios
| Growth Correlation 3m | -70.6% |
| Growth Correlation 12m | -91.6% |
| Growth Correlation 5y | -71.9% |
| CAGR 5y | -28.36% |
| CAGR/Mean DD 5y | -0.47 |
| Sharpe Ratio 12m | -1.94 |
| Alpha | -89.43 |
| Beta | 0.54 |
| Volatility | 103.97% |
| Current Volume | 144.7k |
| Average Volume 20d | 134.1k |
What is the price of DOCM stocks?
As of December 21, 2024, the stock is trading at CHF 19.77 with a total of 144,700 shares traded.
Over the past week, the price has changed by -23.66%, over one month by -35.06%, over three months by -43.21% and over the past year by -70.15%.
As of December 21, 2024, the stock is trading at CHF 19.77 with a total of 144,700 shares traded.
Over the past week, the price has changed by -23.66%, over one month by -35.06%, over three months by -43.21% and over the past year by -70.15%.
Is DocMorris a good stock to buy?
No, based on ValueRay Fundamental Analyses, DocMorris (SW:DOCM) is currently (December 2024) a stock to sell. It has a ValueRay Fundamental Rating of -59.65 and therefor a negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of DOCM as of December 2024 is 13.07. This means that DOCM is currently overvalued and has a potential downside of -33.89%.
No, based on ValueRay Fundamental Analyses, DocMorris (SW:DOCM) is currently (December 2024) a stock to sell. It has a ValueRay Fundamental Rating of -59.65 and therefor a negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of DOCM as of December 2024 is 13.07. This means that DOCM is currently overvalued and has a potential downside of -33.89%.
Is DOCM a buy, sell or hold?
DocMorris has no consensus analysts rating.
DocMorris has no consensus analysts rating.
What are the forecast for DOCM stock price target?
According to ValueRays Forecast Model, DOCM DocMorris will be worth about 14.2 in December 2025. The stock is currently trading at 19.77. This means that the stock has a potential downside of -28.22%.
According to ValueRays Forecast Model, DOCM DocMorris will be worth about 14.2 in December 2025. The stock is currently trading at 19.77. This means that the stock has a potential downside of -28.22%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 48.6 | 145.7% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 14.2 | -28.2% |